BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27396902)

  • 21. [Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?].
    Sargos P; Larré S; Chapet O; Latorzeff I; Fléchon A; Roubaud G; Orré M; Belhomme S; Richaud P
    Cancer Radiother; 2017 Feb; 21(1):67-72. PubMed ID: 28187997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience.
    Ibrahimpasic T; Ghossein R; Carlson DL; Chernichenko N; Nixon I; Palmer FL; Lee NY; Shaha AR; Patel SG; Tuttle RM; Balm AJ; Shah JP; Ganly I
    Thyroid; 2013 Aug; 23(8):997-1002. PubMed ID: 23311700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control.
    Brierley J; Tsang R; Simpson WJ; Gospodarowicz M; Sutcliffe S; Panzarella T
    Thyroid; 1996 Aug; 6(4):305-10. PubMed ID: 8875751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Operative management of locally advanced, differentiated thyroid cancer.
    Wang LY; Nixon IJ; Patel SG; Palmer FL; Tuttle RM; Shaha A; Shah JP; Ganly I
    Surgery; 2016 Sep; 160(3):738-46. PubMed ID: 27302105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
    Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
    Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
    Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Xu Y; Zhang M; Yue Q; Zong J; Lin J; Sun R; Qiu S; Lin S; Pan J
    Cancer Radiother; 2016 Jul; 20(5):377-83. PubMed ID: 27372558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different outcomes in sporadic versus familial medullary thyroid cancer.
    Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
    Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and tolerance of salvage curative radiotherapy for patients with cervical relapse of differentiated thyroid carcinoma].
    Giraud P; Blais E; Jouinot A; Wasserman J; Ménégaux F; Leenhardt L; Maingon P; Simon JM
    Cancer Radiother; 2022 May; 26(3):458-466. PubMed ID: 34253422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
    Roche AM; Fedewa SA; Chen AY
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
    Panigrahi B; Roman SA; Sosa JA
    Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical treatment and prognosis analysis on medullary thyroid carcinoma].
    Zhang ZX; Li ZJ; Tang PZ; Xu ZG; Zhang ZM; An CM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):209-13. PubMed ID: 21575412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
    Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmastectomy radiotherapy of the chest wall. Comparison of electron-rotation technique and common tangential photon fields.
    Hehr T; Classen J; Huth M; Durst I; Christ G; Bamberg M; Budach W
    Strahlenther Onkol; 2004 Oct; 180(10):629-36. PubMed ID: 15480511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study.
    Naik A; Gurjar OP; Gupta KL; Singh K; Nag P; Bhandari V
    Cancer Radiother; 2016 Jul; 20(5):370-6. PubMed ID: 27368915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.